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INTRODUCTION
Atherothrombosis (AT), fatty liver (FL) and gallstone 
disease (GD) represent a clinically heterogeneous group 
of  disorders which commonly occur in the general 
population and impose a heavy economic burden for 
direct and indirect health expenditures[1-4]. Given that 
insulin resistance is an acknowledged risk factor for their 
development[5-7], it is expected that AT, non-alcoholic 
fatty liver disease (NAFLD), one of  the most common 
etiologies of  fatty liver, and GD might often affect the 
same individuals. Several studies have suggested a link 
between NAFLD and endothelial dysfunction, carotid 
intima-media thickening (IMT) and carotid plaques[8-10]. 
However, the development of  AT is a complex process 
involving endothelial dysfunction and IMT as early 
lesions. IMT, in particular, does not represent defi nite AT 
disease but rather it is a marker for its development[10]. In 
addition, some previous studies may not be representative 
of  NAFLD due to enrollment of  only male patients in 
a narrow range of  body mass index (BMI) and age[11,12]; 
therefore, the occurrence of  increased cardiovascular risk 
in NAFLD remains a controversial issue[13,14]. 
NAFLD patients might theoretically be prone to GD 
via impaired gallbladder motility and increased bile litho-
genicity. Both physiopathologic mechanisms occur in 
type 2 diabetes mellitus (T2DM) and obesity, which are 
often associated with NAFLD[7]. However, the NAFLD-
GD association remains uncertain given that it has been 
reported in some studies but rejected in others[15-18]. Fur-
thermore, the association between AT and GD has been 
reported[19-21], but some authors argue this association 
might be spurious and infl uenced by confounders[22]. Al-
though they share a common pathogenetic mechanism, 
AT, GD and NAFLD occur to a different extent in vari-
ous age groups. For instance, increasing age is a risk factor 
for the development of  AT and GD[1,4] but a protective 
factor for NAFLD[23]. Given that no previous studies have 
evaluated simultaneously the occurrence of  AT, GD and 
FL, we evaluated the patterns of  age distribution of  FL of  
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Abstract
AIM: To evaluate carotid intima-media thickening (IMT) 
and plaques, gallstone disease (GD) and fatty liver (FL) 
as a function of age. 
METHODS: In 449 subjects, FL and carotid disease 
were assessed ultrasonographically. In a subgroup of 
65/449 patients with non-alcoholic fatty liver disease 
(NAFLD), carotid disease, GD and associated factors 
were determined. 
RESULTS: FL of unspecifi ed etiology was more common 
in younger and GD in older individuals. FL subjects 
had an increased prevalence of IMT and a decreased 
prevalence of plaques and manifested carotid disease 
earlier. Plaques were more common in subjects with GD. 
Age was an independent predictor of carotid disease 
outcome and FL was a protective factor for plaques. In 
NAFLD, there was an inverse correlation between body 
weight and age and the latter independently predicted 
carotid fi ndings. 
CONCLUSION: Cardiovascular risk in patients with FL 
and NAFLD needs to be assessed as a function of age 
and body weight. 
© 2006 The WJG Press. All rights reserved.
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unspecified etiology and its association with carotid dis-
ease and GD in either gender across a wide range of  age-
groups. In addition, we also assessed the independent pre-
dictors of  carotid disease in a subgroup of  patients with 
defi nite NAFLD.
MATERIALS AND METHODS
Patients
The electronic database of  ultrasound reports for in- and 
out-patients examined at Modena City Hospital (Operating 
Unit Internal Medicine and Gastroenterology, to whom 
one of  the authors belonged at the time when data were 
collected) was searched. Criteria for inclusion in the study 
were to have undergone both liver and carotid ultrasono-
graphic assessment in the same day or, in any case, not 
later than 12 mo apart. Focal liver lesions, ascites or other 
ultrasonographic stigmata of  portal hypertension (such as 
ascites, splenomegaly, presence of  patent umbilical vein, 
varices in the hepato-gastric ligament or spontaneous 
spleno-renal shunts) were criteria for exclusion. Approxi-
mately 1200 liver ultrasound examinations per year were 
recorded in the 1993-2005 period of  time; out of  them, all 
449 subjects fulfi lling the enrollment criteria were selected. 
In 384 of  449 cases, information on gender, age, pres-
ence/absence of  FL and evaluation of  carotid morphol-
ogy was available. No information on being in- or out-
patient, fi nal diagnosis, etiology of  FL or anthropometric 
and biochemical data was included in the software of  the 
electronic database. Sixty-fi ve of  449 subjects were part of  
the series recruited into the POLISTENA study and thus 
their bright livers were due to NAFLD. In this sub-group, 
in addition to the previous parameters including liver and 
carotid US evaluation, a complete history, anthropometric 
parameters and metabolic data were also available as a part 
of  the protocol of  the POLISTENA study[24,25]. 
In the entire population of  449 subjects, we evaluated 
the prevalence of  FL of  unspecifi ed etiology and its rela-
tionship with the US carotid fi ndings and GD. In the sub-
group of  65 NAFLD patients, the prevalences of  carotid 
alterations, GD and the associated factors were determined.
Parameters evaluated in the whole population
Fatty liver of  unspecified etiology: The presence of  
FL was evaluated through ultrasound scanning with a 3.5 
MHz commercially available transducer and defi ned by the 
main criterion of  “bright” liver as described elsewhere[26]. 
Additional diagnostic criteria considered were vessel blur-
ring and posterior attenuation of  the ultrasound beam. 
Ultrasound was performed by trained physicians who 
were unaware of  the results of  the carotid evaluation. The 
evaluation of  presence/absence of  FL among the various 
operators was evaluated using Chi-square test and no sig-
nifi cant difference was found. 
Gallstone disease: GD was defi ned by the presence of  
one or more echogenic, distal acoustic shadowing, possibly 
moveable structures in the gallbladder or empty gallblad-
der fossa in a subjects with a history of  cholecystectomy[7].
Carotid intima-media thickening and plaque: Carotid 
ultrasound evaluation was performed by a single trained 
operator who was blind to the clinical features of  patients. 
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Repeated measurements on the same subject gave coef-
ficients of  variation within 5%. The imaging unit was a 
commercially available machine (AU 600, Hitachi Medical 
Co., Tokyo, Japan) equipped with a 5-MHz linear array 
commercially available transducer. The pulsed Doppler 
frequency was 4.0 MHz. The imaging protocol[27] involved 
scanning along the entire course of  the cervical carotid 
artery from the supraclavicular notch cephalad to the angle 
of  the mandible. Examination of  the right and left com-
mon and internal carotid arteries was also performed. The 
maximum wall thickness observed for either side was taken 
into consideration. Findings were classifi ed as: (1) normal 
(intima < 1 mm); (2) intimal thickening (intima-media 
measuring ≥ 1 mm and < 1.3 mm); and (3) plaque (focal 
widening of  the vessel wall relative to adjacent segments 
≥ 1.3 mm) or complicated plaque (any plaque narrowing 
> 70% of  the lumen).  
Parameters evaluated in the subset of patients with 
NAFLD
Diagnosis of  NAFLD: The diagnosis of  NAFLD in 
the subgroup of  65 patients enrolled in the POLISTENA 
study was based on: (1) absent-to-low alcohol consump-
tion (≤ 30 g alcohol daily for men and ≤ 20 g for wom-
en); (2) evidence of  FL at ultrasound scanning as detailed 
above; and (3) absence of  alternative etiologies of  chronic 
liver disease, notably viral, autoimmune, thyroid, drug-
induced, hemodynamic and genetic-metabolic (alpha1-
antitrypsin, hemochromatosis, Wilson disease). In addition 
to abdominal ultrasonography and ultrasound carotid 
scanning, all patients underwent a questionnaire, physical 
examination and blood sampling for biochemical analysis. 
In 23 of  65 subjects, liver biopsy was clinically indicated on 
the grounds of  hepatomegaly and/or particularly altered 
liver function tests and was performed under ultrasound 
guidance.
Questionnaire: The questionnaire investigated family and 
personal history, including concurrent diseases, previous 
surgery, past and current use of  medications, possible con-
tacts with toxic agents. Alcohol intake, smoking habits and 
physical activity were also recorded. Alcohol consumption 
was assessed through separate interviews with the patient, 
the referring physician, and family members. Subjects were 
classified as never smokers (never smoked currently or 
in the past 5 years) or current smokers. The latter group 
comprised those smokers of  as much as one cigarette a 
day and also included those ex-smokers who had quitted 
tobacco since less than 5 years. Physical activity was de-
fi ned as any exercise, such as jogging, swimming, attending 
a gymnastics course, cycling, playing tennis, dancing or 
heavy gardening. Based on their leisure time physical activ-
ity, subjects were classifi ed as sedentary (those exercising 
less than 1 h per week) or non-sedentary (all the others). 
General physical examination: It was performed by one 
of  the senior authors. Anthropometric parameters and 
blood pressure measurements were performed by a trained 
nurse. Waist girth was measured at the smallest circumfer-
ence between the ribs and the iliac crest and hip at the 
maximum circumference between the iliac crest and the 
crotch. Waist-hip ratio (WHR) was calculated as waist cir-
cumference/hip circumference.
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Laboratory tests: Laboratory evaluation included renal 
and liver function tests, blood cell count, total and frac-
tionated proteins, parameters of  iron metabolism (serum 
iron, transferrin and ferritin), lipid profi le (total cholesterol, 
HDL-cholesterol, LDL-cholesterol, triglycerides, apo-A, 
apo-B), fasting glucose, fasting insulin, and uric acid. Se-
rum concentrations of  copper, ceruloplasmin and alpha1-
antitrypsin were performed to exclude Wilson disease and 
alpha1-antitrypsin defi ciency. Non-organ-specifi c autoanti-
bodies were also evaluated. In all patients, the presence of  
viral serologic markers for B and C infection was assessed 
by standard methods. Insulin resistance was calculated ac-
cording to the Homeostasis Model Assessment of  Insulin 
Resistance (HOMA-IR) index computed through the for-
mula: fasting serum insulin (μU/mL) × fasting serum glu-
cose (mmol/L)/22.5[28]. The diagnosis of  impaired glucose 
tolerance and diabetes was based on the American Diabe-
tes Association criteria[29]. Subjects with impaired glucose 
tolerance included individuals with fasting glucose levels 
≥ 6.1 mmol/L but < 7 mmol/L and with a 2-h post-load 
glucose ≥ 140 mg/dL (7.8 mmol/L) and < 200 mg/dL 
(11.1 mmol/L). Diabetes prevalence was based on the 
number of  individuals with fasting plasma glucose ≥ 
126 mg/dL (7 mmol/L) checked twice or having a past 
history of  diabetes[29]. Body mass index (BMI) was calcu-
lated with the formula: mass (kg)/height (m)2 and obesity 
was defi ned by BMI ≥ 30 kg/m2. Normal limits for blood 
lipids were defi ned accordingly to the third report of  the 
National Cholesterol Education Program (NCEP). Hyper-
cholesterolemia was defi ned as serum cholesterol ≥ 5.10 
mmol/L, hypertriglyceridemia as serum triglycerides ≥ 
1.65 mmol/L[30]. Hypertension was diagnosed if  patients 
had a past history of  hypertension, were taking antihyper-
tensive drugs or had a blood pressure ≥ 140/90 mmHg. 
Liver biopsy: Sections were stained with H&E; silver stain 
for reticulin, Sirius red for collagen, periodic acid Schiff  
for glycogen, periodic Schiff-diastase for glycoproteins, 
and Perl’s for iron. Liver biopsy specimens were consid-
ered to be adequate if  6 or more portal tracts were in-
cluded. Evaluation of  steatosis and fi brosis was performed 
following the criteria developed by Brunt et al[31]. A diag-
nosis of  NASH required the following features: steatosis, 
parenchymal infl ammation and ballooning degeneration of  
hepatocytes with or without fi brosis and Mallory bodies[32].
Informed written consent was obtained from all parti-
cipating individuals before taking blood samples and prior 
to liver biopsy. The study was performed in agreement 
with the Declaration of  Helsinki.
Statistical analysis
Data were expressed as mean ± SE for variables nor-
mally distributed and as median (25th-75th percentile) for 
those not normally distributed. Normalization of  age was 
achieved through square transformation. The following 
tests were used as appropriate: Chi-square, Mann-Whitney, 
Oneway Scheffe’s test, ANOVA, linear regression, binary 
logistic regression. Given that vascular carotid disease 
may manifest three different features (normal findings, 
IMT and plaques), we chose to adopt multinominal logis-
tic regression which enables us to keep this distinction in 
carotid ultrasonographic fi ndings. The software used was 
SPSS Inc. Chicago, Illinois USA, release 14.0.
RESULTS
Data analysis in the whole population
Of  the 449 subjects fulfilling enrollment criteria, 203 
(45.2%) were men and 246 (54.8%) women; the median 
of  the age was 69 years (56.5-78 years). Men were younger 
[median: 66 years (53-76 years)] than women [median: 72 
years (59-81.25)] (Mann-Whitney test, Z = - 3.419, P = 
0.001).
Fatty liver of unspecifi ed etiology
FL was present in 42.1% (189/449) of  subjects, and the 
majority (102/189, 54.0%) were males (χ2 = 10.104, P = 
0.0014). The distribution of  FL per age-group is shown 
in Figure 1. The median age of  the subjects with FL was 
62 years (49-72 years) versus 75 years (65-81.75) in those 
without FL (Mann-Whitney test, Z = -7.479, P = 7.52 × 
10-14). Logistic regression analysis using FL as the depend-
ent variable and age and sex as predictors disclosed OR = 
-0.956, 95% CI = 0.943-0.969 (P = 2.12 × 10-10) for age 
and OR = -0.631, 95% CI = 0.422-0.942 (P = 0.024) for 
sex, demonstrating that FL is more common in younger 
male individuals. 
Gallstone disease
The overall prevalence of  GD was 32.5% (146/449), not 
signifi cantly different in patients with FL versus those with-
out FL (28.6% vs 35.2%; χ2 = 2.315, P = 0.128). Patients 
with GD were older than those without GD [73 years 
(61-82 years) vs 68 years (53-77 years); Mann-Whitney 
test, Z = -3.497, P = 0.00047] and GD was present more 
often in women than in men (38.6% vs 25.1%; χ2 = 9.230, 
P = 0.002). Logistic regression analysis using GD as the 
dependent variable confi rmed that advanced age and fe-
male gender rather than steatosis predict the presence of  
GD (OR for age: 1.024, 95% CI: 1.009-1.039, P = 0.002; 
OR for female gender: 1.698, 95% CI = 1.118-2.578, P 
= 0.013). Fifty-four subjects had concurrent FL and GD. 
Compared with subjects with FL alone, these patients had 
more advanced median age [64 years (53-73 years) vs 60 
Figure 1  Distribution of ultrasonographically diagnosed fatty liver of unspecifi ed 
etiology in the various age-groups of adulthood. The number of patients enrolled 
in each age-group is as follows: < 30: 8 cases; 30-39: 19 cases; 40-49: 44 cases; 
50-59: 64 cases; 60-69: 98 cases; 70-79: 119 cases; and >80: 97 cases.
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years(48-71 years); Mann-Whitney test, Z = -2.121, P = 
0.034], but there was no female gender prevalence (females 
55.6% vs males 44.0%; χ2 = 2.76, P = 0.097).
Carotid ultrasonographic-Doppler evaluation
Fifty-eight of  449 subjects (12.9%) had normal carotid 
ultrasonographic findings. IMT was found in 16.0% 
(72/449) of  subjects; the prevalence of  atherosclerotic 
plaques was 71% (319/449). The distribution of  carotid 
lesions per age-group is shown in Figure 2. All 8 subjects 
aged < 30 years had normal carotid findings (Figure 2). 
Carotid ultrasonographic-Doppler evaluation showed that 
median age was 45 years (33.75-55.25) for normal, 58 years 
(48.25-65) for IMT, 75 years (65-81) for plaques (Scheffe’s 
Oneway on squared age F = 134.118; P = 2.48 × 10-46). 
Relationship between FL of unspecifi ed etiology, GD and 
carotid ultrasonographic-doppler fi ndings
Table 1 summarises carotid fi ndings as a function of  pres-
ence/absence of  FL. The frequency of  subjects with IMT 
was more than two-fold in those with FL than in those 
without FL (23.8% vs 10.4 %). In contrast, the prevalence 
of  plaques was decreased in those with FL of  unspecifi ed 
etiology than in those without it (55.6% vs 82.3%; χ2 = 
38.373, P  =  4.65 × 10-10).
Table 2 shows median age and 25th-75th percentile in 
subjects with/without FL as a function of  carotid fi ndings. 
Following normalization obtained through square eleva-
tion, age was compared through ANOVA. Carotid fi ndings 
(F = 114.457, P = 8.47 × 10-41) and FL (F = 6.311, P = 
0.012) rather than gender (data not shown, F =1.529, P = 
0.217) were statistically different. Subjects with GD had a 
higher prevalence of  plaques than those without plaques 
(78.8% vs 67.3%; χ2 = 8.351, P = 0.015) (Table 3). In or-
der to determine those variables that were predictive of  
plaques or IMT, multinominal logistic regression was used. 
Carotid fi ndings were the dependent variable (normal as 
the reference value) and age and gender as fi xed covariates; 
factors were FL and GD (forward). As shown in Table 4, 
age turned out to be an independent predictor of  ultra-
sonographic carotid outcome, OR for IMT being 1.082 
(95% CI: 1.048-1.117, P = 1.40 × 10-6) and for plaques 1.181 
(95% CI: 1.140-1.228, P = 2.27 × 10-20). The presence of  
FL was a protective factor for plaques (OR = 0.418, 95% 
CI: 0.185-0.945, P = 0.036) rather than for IMT (OR = 
0.911, 95% CI: 0.443-2.169, P = 0.827).
Data analysis of the subset of patients with NAFLD
In 65 of  449 subjects belonging to the POLISTENA 
Table 1  Ultrasonographic carotid fi ndings in subjects with or 
without fatty liver of unspecifi ed etiology
                              Fatty liver 
Carotid fi ndings         Absent n  (%)      Present  n  (%)         P
Normal                          19 (7.3)                  39 (20.6)
IMT                          27 (10.4)                  45 (23.8)
Plaques                        214 (82.3)                105 (55.6)             P = 4.65 × 10-10
χ2 test.
Table 2  Median age and 25th-75th percentile of subjects with/
without fatty liver of unspecifi ed etiology (classifi ed according 
to carotid fi ndings)
                                              Fatty liver
Carotid fi ndings         Absent n  (%)                  Present n  (%)
Normal 44 (31-52) 46 (34-58)
IMT 65 (51-71) 56 (48-62.5)
Plaques 76 (68.75-82) 68 (60.5-78)
Table 3  Carotid ultrasonographic fi ndings in subjects with or 
without gallstone disease
                                         Gallstone disease 
Carotid fi ndings Absent n  (%)     Present n  (%)          P 
Normal   48 (15.8)   10 (6.8)  
IMT   51 (16.8)   21 (14.4)
Plaques 204 (67.3) 115 (78.8)  P = 0.015
χ2 test.
  Carotid 
  fi ndings
             
          B
     Standard 
       error   P 
   Exp (B) 
(95% CI )
Table 4  Independent predictors of intima-media thickening 
(IMT) or plaques in fatty liver of unspecifi ed etiology
  IMT Intercept  -3.736   0.916   0.000
 Male  -0.019   0.405   0.962      0.981
(0.443-2.169)
 Age   0.079   0.016   0.0000014      1.082
(1.048-1.117)
Fatty liver   0.093   0.426   0.827       0.911
(0.395-2.101)
  Plaques Intercept  -7.879   1.050   0.000
Male   0.042   0.403   0.1719      1.719
(0.781-3.786)
 Age   0.166   0.018   2.27 × 10-20       1.181
(1.040-1.223)
 Fatty liver   0.873   0.416   0.036       0.418
(0.185-0.945)
Multivariate multinominal logistic regression. Dependent variable: carotid 
findings (IMT or plaques). Reference category: normal carotid findings. 
Age, sex (forced entry terms), fatty liver and GD (forward entry term) were 
entered as covariates.
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Figure 2  Distribution of carotid ultrasound fi ndings in the various age-groups of 
adulthood. The number of patients enrolled in each age-group is the same as 
reported in Figure 1.
Lonardo A et al. Fatty liver, atherosclerosis and gallstones                                                              5829
www.wjgnet.com
study[23,24], ultrasound carotid examination was also per-
formed. These patients had an average age of  53.42 ± 
1.38 years. Thirty-one of  65 (47.7%) were males with an 
average age of  48.06 ± 2.03 years, which was signifi cantly 
lower than the age observed in women 58.29 ± 1.44 years (t 
= -4.159, P = 0.00001). The prevalence of  components of  
the metabolic syndrome was as follows: hypercholestero-
lemia 72.3% (47/65); arterial hypertension 38.4% (25/65); 
obesity 36.9% (24/65); hypertriglyceridemia 33.85% 
(22/65); IGT 27.7% (18/65); and T2DM 21.5% (14/65). 
Out of  65 patients, 10 (15.4%) had GD. These GD pa-
tients were older than those without GD (59.00 ± 1.65 
years vs 52.40 ± 1.56; t = -2.91, P = 0.007), with a similar 
proportion of  males and females (9.68% vs 20.59%; Fisher’
s exact test, P = 0.309).
Patients with normal carotid findings were younger 
than those with IMT and with plaques (Oneway Scheffe’
s test, F = 7.652, P = 0.001). Individuals with plaques had 
lower body weight (Oneway Scheffe’s test, F = 3.878, P = 
0.026) and transferrin serum levels (Oneway Scheffe’s test, 
F = 4.491, P = 0.015) than those with normal carotid fi nd-
ings (Table 5), indicating a signifi cant inverse relationship (r2 
= 0.116; P = 0.006) between age and body weight (Figure 3). 
We also found a direct relationship between HOMA and 
BMI (r2 = 0.26, P = 0.000017) rather than between HOMA 
and age. No relationship was found between histological 
variables and carotid ultrasonographic fi ndings in the lim-
ited number of  cases available (Table 6).
The distribution of  carotid ultrasonographic fi ndings 
in the various age-groups of  adulthood is shown in Figure 
Table 6  NAFLD. Hepatic histological findings in NAFLD 
patients with normal carotid fi ndings, intima-media thickening 
(IMT) and atherosclerotic carotid plaques1
                           Carotid fi ndings 
Hepatic
histology           Normal n  (%)  IMT n  (%)  Plaques n  (%)        p
Infl ammatory 
    grade
          0 2 (29) 1 (10) 2 (33)
          1 3 (43) 5 (50) 2 (33)
          2 2 (29) 2 (20) 2 (33)
          3 0 (0) 2 (20) 0 (0) 0.5162
Fibrosis  stage
          0 5 (71) 7 (70) 5 (83)
          1 1 (14) 1 (10) 1 (17)
          2 1 (14) 2 (20) 0
          3 0 0 0
          4 0 0 0 0.7622
Steatosis 
extent  (%)
45.8 ± 9.9 51.0 ± 8.9 23.00 ± 5.4 0.1313
123 of 65 NAFLD patients underwent liver biopsy; 7 had normal findings, 
10 IMT, and 6 carotid plaques. 2Kruskall-Wallis test; 3One way analysis of 
variance. 
140
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Figure 3  Inverse correlation between body weight and age in NAFLD patients.
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Table 5  Historical, anthropometric and laboratory fi ndings of 
subjects with NAFLD as a function of ultrasonographic carotid 
fi ndings (mean ± SE, 25th-75th percentile)
Variable     Normal 
  (n° 19)
     IMT
   (n° 30)
 Plaques 
 (n° 16)
P
Age  (yr)   46.11 ± 2.66   55.23 ± 1.59   58.69 ± 2.67 0.001
Gender  (M/F)        10/9       13/17         8/8 NS 
Smokers          8/17       10/30         6/16 NS
Physical exercise          5/17       11/30         6/16 NS
BMI (kg/m2)   31.05 ± 1.40   28.85 ± 0.68   27.30 ± 0.85 NS
Mass (kg)         87.21 
  (76.00-100.00)
        79.9 
  (71.00-88.50)
      74.28.50 
  (66.50–84.00)
0.026
Waist (cm) 102.53 ± 2.73   96.81 ± 2.02   95.31 ± 2.19 NS
Hip  (cm) 114.79 ± 3.31 109.30 ± 1.52 107.31 ± 1.44 NS
W/H ratio     0.90 ± 0.02     0.89 ± 0.01     0.89 ± 0.02 NS
Arterial 
pressure 
(mmHg)
D: 80.0
    (70.0-80.0)
S: 120.0   
  (120.0-130.0)
D: 80.0  
    (80.0-80.0)
S: 130.0 
  (120.0-130.0)
D: 80.00
 (80.00-87.5)
S: 130.0      
(120.0-145.0) 
NS
Fasting glucose 
(mmol/L)
          5.55 
    (4.75-6.54) 
          5.39
    (5.05-5.83) 
           5.28 
    (4.99-5.65) 
NS
Uric acid 
(μmol/L)
345.29 ± 21.76 333.52 ± 14.11 315.88 ± 18.23 NS
Total cholesterol 
(mmol/L)
    5.37 ± 0.26     4.15 ± 0.21    5. 91 ± 0.18 NS
HDL Cholesterol 
(mmol/L)
    1.20 ± 0.06     1.25 ± 0.06     1.21 ± 0.06 NS
Triglycerides  
(mmol/L)
          1.46 
    (0.99-2.05)
          1.49
    (1.18-1.98)
          1.64 
   (1.49 - 2.00)
NS
AST 
(IU/L) 
        26.00 
  (23.00-35.00)
        25.00
  (21.00-31.50)
        23.50   
  (19.50-29.50)
NS
ALT 
(IU/L)
        53.00
  (35.00-74.00)
        39.00
  (29.50-54.00)
        36.00 
  (23.25-40.00)
NS
GGT  
(IU/L)
        40.00  
  (29.00-71.00)
        30.00
  (21.00-71.00)
        33.00 
  (24.25-49.25)
NS
Fasting 
insulin 
(pmol/L)
      119.82
  (86.81-145.65)
      108.70
 (79.28-164.88)
        80.71
  (60.62-109.77)
NS
Insulin 120 min 
post-load  
(pmol/L)
      499.38
(269.78-1442.18)
      767.72 
(324.31-1379.39)
      554.26
(383.50-770.45)
NS
APO A 
(mg/dL)
139.80 ± 7.73 144.58 ± 4.74 137.64 ± 6.03 NS
APO B
(mg/dL)
  98.00 ± 6.61 111.15 ± 5.04 110.73 ± 6.39 NS
Iron  
(μmol/L)
  16.34 ± 1.04   16.58 ± 0.89   15.99 ± 1.39 NS
Ferritin 
 (mg/dL)
122.68 ± 23.64 129.00 ± 17.95 175.36 ± 30.22 NS 
Transferrin  
saturation (%)
  25.99 ± 1.72   29.33 ± 1.80   28.17 ± 2.86 NS
Fibrinogen
(g/L)
    3.16 ± 0.18     3.53 ± 0.14     3.33 ± 0.22 NS
HOMA-IR 
 index
          4.207
  (2.936-5.941)
          3.864
  (2.708-5.869)
          2.815
  (2.256-3.861)
NS
Lp(a) 
(mg/dL)
        35.00
    (8.50-77.00)
        12.00
    (4.00-30.00)
          9.00 
    (5.50-28.5)
NS
Signifi cance of the comparisons evaluated through oneway Scheffe’s test for 
variable normally distributed, and Kruskall Wallis for those not normally 
distributed.
4. Variables associated with IMT and plaques (the refer-
ence being normal fi ndings) were evaluated using univari-
ate logistic multinominal regression, where age, BMI and 
HOMA were found to be signifi cant independent predic-
tors (data not shown). In the multivariate logistic multi-
nominal regression (Table 7), only age turned out to be 
the signifi cant independent predictor of  carotid IMT (OR: 
1.091, 95% CI: 1.021-1.165, P = 0.010) and plaques (OR: 
1.126, 95% CI: 1.037-1.223, P = 0.005).
DISCUSSION
To the best of  our knowledge, this is the fi rst study which 
explores the prevalence and determinants of  carotid dis-
ease, FL and gallstones. A major fi nding of  this study was 
that distribution of  FL per age-classes (Figure 1) peaked 
in the 30-49 years age-group and declined in the younger 
and more advanced age groups. This “inverted U” pattern 
resembles that reported for FL distribution in the general 
population in Japan[15] and closely mirrors the curve of  al-
tered transaminase levels in USA[33,34] and in Israel[35]. Tak-
en collectively, these data further support the theory that 
FL, most likely NAFLD, accounts for the vast majority of  
altered liver function tests (LFTs) in the Western world. 
We have no explanation as to why the prevalence of  FL 
of  unspecifi ed etiology declined after the age of  49 years. 
Several hypotheses can be put forward. The phenomenon 
may refl ect a simple decrease in risk factor for NAFLD, 
notably including obesity, as supported by the fi nding in 
the present study that body weight declines with age (Figure 
3). An alternative explanation is that mortality might be 
selectively increased among those with FL of  unspecifi ed 
etiology. A recent study has shown that the presence of  
NAFLD is associated with an increased mortality as com-
pared with the general population[36]. A unifying explana-
tion could be that only those NAFLD subjects who lose 
weight will survive till more advanced age. This hypothesis, 
though, remains speculative and needs support from pro-
spective studies. 
Relevant fi ndings of  this study are that subjects with 
FL of  unspecified etiology had an increased prevalence 
of  IMT and a decreased prevalence of  plaques; in con-
trast, GD was associated with increased prevalence of  
plaques. Of  interest, carotid disease was found to occur in 
FL patients approximately 8 to 9 years earlier than those 
observed in subjects without FL. In FL of  unspecified 
etiology, age was found to be an independent predictor 
of  IMT and plaques, and steatosis had a protective effect 
in plaques only. Age was also recognized as the only inde-
pendent predictor of  carotid fi ndings in NAFLD.
Although the prevalence of  IMT among subjects with 
FL of  unspecifi ed etiology was increased, FL of  unspeci-
fi ed etiology was not shown an independent predictor of  
IMT and was a negative predictor of  plaques at logistic 
regression multinominal analysis; in contrast, GD and ca-
rotid plaques were shown to be associated. These fi ndings 
can all be accounted for by the influence of  age on the 
diseases in study. IMT and FL of  unspecifi ed etiology had 
the same distribution per age-classes, namely decreased in 
individuals aged > 40 years, whereas carotid atherosclerosis 
and GD increased in such over-40-year-old subjects (Fig-
ure 1). An increased prevalence of  IMT among subjects 
with FL has also been reported in previous studies[9,37]. 
However, while these authors reported the absolute value 
of  IMT expressed in mm, we used a > 1-1.3 mm cut-off  
value, namely the threshold level predicting the occurrence 
of  cardiovascular events[38]. These methodological differ-
ences imply that we might have underestimated the true 
prevalence of  IMT among subjects with FL of  unspecifi ed 
etiology to the advantage of  predicting clinically relevant 
events. A recent study[39] showed that after adjustment for 
confounders, NAFLD was significantly associated with 
an increased risk of  cardiovascular diseases. However, ad-
ditional adjustment for the metabolic syndrome appreci-
ably attenuated this association without abolishing it. The 
fi nding that FL of  unspecifi ed etiology is an independent 
negative predictor of  carotid plaques is probably linked to 
the inverse relationship linking age and body weight (Figure 
3). Therefore, we emphasize that these data do not sup-
port a true “protective” effect of  FL of  unspecifi ed etiol-
ogy on the development of  carotid plaques but probably 
represent the effect of  selective mortality in those with FL 
and advanced AT, as suggested by the fi nding in this study 
that those with FL and IMT or plaques were 8 to 9 years 
younger than those with the same carotid fi ndings without 
Carotid Standard Exp (B)
fi ndings      B error    P 1   (95% CI )
Table 7  Independent predictors of intima-media thickening 
(IMT) or plaques in NAFLD subjects
IMT Intercept -0.955 2.648 0.718
 Age  0.087 0.034 0.010 1.091 (1.021-1.165)
 BMI -0.102 0.071 0.150 0.903 (0.785-1.038)
Plaques Intercept -0.913 3.628 0.801
 Age  0.119 0.042 0.005 1.126 (1.037-1.223)
 BMI -0.189 0.097 0.052 0.828 (0.684-1.002)
1Multivariate multinominal logistic regression. Dependent variable: carotid 
findings (IMT or plaques). Reference category: normal carotid findings. 
Age, body mass (forced entry terms) and HOMA (forward entry term) were 
entered as covariates. 
Figure 4  Distribution of carotid ultrasound fi ndings in the various age-groups of 
adulthood with NAFLD. The number of patients enrolled in each age-group is as 
follows: < 30: 2 cases; 30-39: 4 cases; 40-49: 16 cases; 50-59: 25 cases; 60-69: 
14 cases; and 70-79: 4 cases.
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FL.
Our data confirm the association between GD and 
carotid plaques[20,21] but, in agreement with a previous 
study[17], challenge that between GD and NAFLD. Both 
these findings are accounted for by the fact that carotid 
disease and GD both increase, whereas FL of  unspecifi ed 
etiology decreases, with age. 
The importance of  distribution per age-groups of  
subjects with various carotid findings, FL, NAFLD and 
GD also links the fi rst (FL of  unspecifi ed etiology) and 
the second part (NAFLD) of  our study. Individuals with 
NAFLD were signifi cantly younger than those included in 
the fi rst part of  the study and thus they were less prone to 
the development of  carotid plaques and GD. We highlight 
that in this subset of  patients where all data were avail-
able, no other anthropometric, biological or histological 
parameters except for age, is an independent predictor of  
IMT and carotid plaques as found in the whole series. This 
fi nding fi ts with a previous study indicating that age is a 
powerful determinant of  maximum IMT in both diabetic 
and healthy subjects[40].
Some studies suggest that NAFLD patients have an 
increased incidence of  carotid atherosclerosis[9,41,42]. How-
ever, there is not enough hard data coming from natural 
history to support or rule out an association between 
NAFLD and cardiovascular disease. Indeed, some follow-
up studies indicate that excess mortality in NAFLD is 
due to liver-related causes rather than to cardiovascular 
events[13,14,36,43]. Enrollment criteria and referral pattern of  
patients might affect the vascular risk in NAFLD patients. 
NAFLD individuals included in our series were young and 
had a low prevalence of  arterial hypertension and reduced 
HDL cholesterol that are strong determinants of  AT[44-46]. 
Furthermore, factors that are associated with the onset of  
carotid plaques might be different from those that cause 
clinical events of  (complicated) AT.
Some specifi c features of  our study need to be empha-
sized. First, the large series of  subjects who were recruited. 
These individuals were distributed across all age-groups 
of  adulthood, so providing an exhaustive cross-sectional 
picture of  the relationship between the variables. Fur-
thermore, our study enabled to evaluate those risk factors 
that add to the background dysmetabolic milieu linked to 
NAFLD per se. Indeed, our “control” group consisted of  
NAFLD patients with normal carotid fi ndings rather than 
of  subjects with a normal liver (i.e. without FL). Finally, 
we used the statistical procedure of  multinominal logis-
tic regression analysis which is particularly suitable in the 
analysis of  unrelated multiple events, such as the varying 
outcomes of  carotid ultrasonographic findings. We ac-
knowledge, however, that ours is not a prospective study 
and that absence of  anthropometric and biochemical data 
in the population with FL of  unspecifi ed etiology together 
with the limited number of  NAFLD subjects may preclude 
exhaustive analysis of  the etiological link between evalu-
ated variables. Furthermore, the indications for prescrib-
ing ultrasound scanning of  the liver or carotid depend on 
the clinical picture displayed by patients rather than by a 
standardized protocol. This may have reduced the number 
of  subjects included in some age-groups (e.g. those aged 
30 to 39 years) because these younger individuals seldom 
present indications to undergo ultrasound scanning of  ca-
rotid. This might somewhat bias our fi ndings, that need to 
be duplicated by future studies.
In conclusion, our data show that in a large population 
comprising all ages of  adulthood, age is an independent 
predictor of  carotid IMT and plaques. FL of  unspecifi ed 
etiology is a negative predictor of  carotid plaques, prob-
ably indicating selective death of  those with FL or disap-
pearance of  liver fat with ageing. While we confirm an 
increased prevalence of  IMT among patients with FL of  
unspecifi ed etiology, and an association of  GD with carot-
id atherosclerosis, we were unable to fi nd any independent 
relationship between any conventional parameters, such as 
anthropometric, metabolic, hemodynamic, and histological 
liver features and carotid disease in NAFLD. In this spe-
cifi c subset of  individuals, again, age is the only independ-
ent predictor of  ultrasonographic carotid fi ndings. Studies 
of  natural history are needed to evaluate the real entity of  
cardiovascular risk in patients with FL of  unspecifi ed etiol-
ogy and NAFLD as a function of  age.
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